Additionally, the LPHN1 mutations we identified in the present study are located further downstream in the C terminus of the receptor compared to the ones described to cause neurodevelopmental disorders (Fig. 5), potentially yielding smaller alterations of the receptor’s function or not impairing splice variants only comprising the N-terminal regions of the aGPCR. The gene discussed is ADGRL1; the disease is neurodevelopmental disorder.